Sphera Funds Management Ltd. Karyopharm Therapeutics Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$14.14 - $19.71 $5.55 Million - $7.74 Million	-392,831 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$16.6 - $25.25 $2.61 Million - $3.97 Million	-157,169 Reduced 28.58%	392,831 $7.44 Million
Q1 2020 May 14, 2020	BUY	$14.38 - $27.72 $3.16 Million - $6.1 Million	220,000 Added 66.67%	550,000 $10.6 Million
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $3.05 Million - $6.49 Million	330,000 New	330,000 $6.33 Million

4.71M

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $358M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.